Drugs / Tralement
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | MULTRYS | — | 2020-07-02 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT05661682 Comparator | Feb → Oct 2025 | — | American Regent, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT05677126 Comparator | Aug 2024 | — | American Regent, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tralement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05677126 ↗ |